Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0000899243-20-025722

Director sold 8,965 shares at $86.98 ($779,777)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Bolzon Bradley J PhD Director 2020-09-16 Sale −8,965 $86.98 $779,777 521,225 I
Open-market sales · 8,965 sh · avg $86.98 · $779,777
Loading xslF345X03/doc4.xml…